Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8472-8480

  Juel, Helene B ^a   Faber, Carsten ^a   Udsen, Maja S ^a   Folkersen, Lasse ^b   Nissen, Mogens H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD28; ANTIGENS, CD3; CELL LINE; CHEMOKINES; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOBLOTTING; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873356026     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9963     Document Type: Article

References (63)

1. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol. 2007;44:3901-3908.
2. Kaestel CG, Lovato P, Odum N, Nissen MH, Ropke C. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Curr Eye Res. 2005;30:375-383.
3. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001;20: 29-48.
4. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74:179-185.
5. McMenamin PG. The distribution of immune cells in the uveal tract of the normal eye. Eye (Lond). 1997;11(pt 2):183-193.
6. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345-1351.
7. Xu H, Chen M, Forrester JV. Para-inflammation in the ageing retina. Prog Retin Eye Res. 2009;28:348-368.
8. Streit WJ. Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci. 2006;29: 506-510.
9. Sasahara M, Otani A, Oishi A, et al. Activation of bone marrowderived microglia promotes photoreceptor survival in inherited retinal degeneration. Am J Pathol. 2008;172:1693-1703.
10. Kaneko H, Nishiguchi KM, Nakamura M, Kachi S, Terasaki H. Characteristics of bone marrow-derived microglia in the normal and injured retina. Invest Ophthalmol Vis Sci. 2008; 49:4162-4168.
11. Nakazawa T, Hisatomi T, Nakazawa C, et al. Monocyte chemoattractant protein 1 mediates retinal detachmentinduced photoreceptor apoptosis. Proc Natl Acad Sci U S A. 2007;104:2425-2430.
12. Chen H, Liu B, Lukas TJ, Neufeld AH. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS ONE. 2008;3: e2339.
13. Ali S, O'Boyle G, Mellor P, Kirby JA. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Mol Immunol. 2007;44:1477-1482.
14. Raoul W, Auvynet C, Camelo S, et al. CCL2/CCR2 and CX3CL1/ CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation. 2010;7:87.
15. Juel HB, Kaestel C, Folkersen L, et al. Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T-cells. Exp Eye Res. 2011;92: 180-188.
16. Folkersen L, Diez D, Wheelock CE, et al. GeneRegionScan: a Bioconductor package for probe level analysis of specific, small regions of the genome. Bioinformatics. 2009;25:1978-1979.
17. Browning JL. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol Rev. 2008;223: 202-220.
18. Hochman PS, Majeau GR, Mackay F, Browning JL. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J Inflamm. 1995;46: 220-234.
19. Tian J, Ishibashi K, Honda S, Boylan SA, Hjelmeland LM, Handa JT. The expression of native and cultured human retinal pigment epithelial cells grown in different culture conditions. Br J Ophthalmol. 2005;89:1510-1517.
20. Tian J, Ishibashi K, Handa JT. The expression of native and cultured RPE grown on different matrices. Physiol Genomics. 2004;17:170-182.
21. Elner SG, Elner VM, Bian ZM, et al. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest Ophthalmol Vis Sci. 1997;38:446-455.
22. Elner SG, Delmonte D, Bian ZM, Lukacs NW, Elner VM. Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8. Exp Eye Res. 2006;83:374-379.
23. Ohmori Y, Hamilton TA. IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J Immunol. 1994;153:2204-2212.
24. Wuyts A, Struyf S, Gijsbers K, et al. The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. Lab Invest. 2003;83: 23-34.
25. Boost KA, Sadik CD, Bachmann M, Zwissler B, Pfeilschifter J, Muhl H. IFN-gamma impairs release of IL-8 by IL-1betastimulated A549 lung carcinoma cells. BMC Cancer. 2008;8: 265.
26. Gusella GL, Musso T, Bosco MC, Espinoza-Delgado I, Matsushima K, Varesio L. IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol. 1993;151: 2725-2732.
27. Leung KW, Barnstable CJ, Tombran-Tink J. Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol Immunol. 2009;46:1374-1386.
28. Kumar MV, Nagineni CN, Chin MS, Hooks JJ, Detrick B. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J Neuroimmunol. 2004;153:7-15.
29. Bian ZM, Elner SG, Yoshida A, Elner VM. Human RPEmonocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade. Exp Eye Res. 2003;76:573-583.
30. Judice MR, Bouffioux C, Marcet B, et al. Extracellular nucleotides stimulate interleukin-8 production by ARPE cells: potential role of danger signals in blood retinal barrier activation. Invest Ophthalmol Vis Sci. 2009;50:1241-1246.
31. Wang Y, Bian ZM, Yu WZ, Yan Z, Chen WC, Li XX. Induction of interleukin-8 gene expression and protein secretion by Creactive protein in ARPE-19 cells. Exp Eye Res. 2010;91:135-142.
32. Kurji KH, Cui JZ, Lin T, et al. Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2010;51:1151-1163.
33. Zhu D, Deng X, Xu J, Hinton DR. What determines the switch between atrophic and neovascular forms of age related macular degeneration?-the role of BMP4 induced senescence. Aging (Albany NY). 2009;1:740-745.
34. Austin BA, Liu B, Li Z, Nussenblatt RB. Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2009;50:2896-2902.
35. Ambati J, Anand A, Fernandez S, et al. An animal model of agerelated macular degeneration in senescent Ccl-2-or Ccr-2-deficient mice. Nat Med. 2003;9:1390-1397.
36. Ma W, Zhao L, Fontainhas AM, Fariss RN, Wong WT. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS ONE. 2009;4:e7945.
37. Momma Y, Nagineni CN, Chin MS, Srinivasan K, Detrick B, Hooks JJ. Differential expression of chemokines by human retinal pigment epithelial cells infected with cytomegalovirus. Invest Ophthalmol Vis Sci. 2003;44:2026-2033.
38. Shi G, Maminishkis A, Banzon T, et al. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2008;49:4620-4630.
39. Ludwig A, Weber C. Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb Haemost. 2007;97:694-703.
40. Silverman MD, Zamora DO, Pan Y, et al. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest Ophthalmol Vis Sci. 2003;44:1608-1615.
41. Crane IJ, Xu H, Wallace C, et al. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J Leukoc Biol. 2006;79: 435-443.
42. Newman AM, Gallo NB, Hancox LS, et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 2012;4:16.
43. Raoul W, Keller N, Rodero M, Behar-Cohen F, Sennlaub F, Combadiere C. Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. J Neuroimmunol. 2008;198:56-61.
44. Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64: 110-122.
45. Ross RJ, Zhou M, Shen D, et al. Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp Eye Res. 2008;86:675-683.
46. Luhmann UFO, Ali RR. Local vs. systemic mononuclear phagocytes in age-related macular degeneration and their regulation by CCL2-CCR2 and CX3CL1-CX3CR1 chemokine signaling. Adv Exp Med Biol. 2012;723:17-22.
47. Luhmann UF, Robbie S, Munro PM, et al. The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci. 2009;50:5934-5943.
48. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28:1-18.
49. Janciauskiene S, Westin K, Grip O, Krakau T. Detection of Alzheimer peptides and chemokines in the aqueous humor. Eur J Ophthalmol. 2011;21:104-111.
50. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol. 2010;128:1281-1286.
51. Gupta N, Brown KE, Milam AH. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and agerelated macular degeneration. Exp Eye Res. 2003;76:463-471.
52. Combadiere C, Feumi C, Raoul W, et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest. 2007;117:2920-2928.
53. Muller M, Carter S, Hofer MJ, Campbell IL. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity-a tale of conflict and conundrum. Neuropathol Appl Neurobiol. 2010;36:368-387.
54. Greenwood J, Howes R, Lightman S. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage. Lab Invest. 1994;70:39-52.
55. Rappert A, Bechmann I, Pivneva T, et al. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci. 2004;24:8500-8509.
56. Li H, Gang Z, Yuling H, et al. Different neurotropic pathogens elicit neurotoxic CCR9-or neurosupportive CXCR3-expressing microglia. J Immunol. 2006;177:3644-3656.
57. Muller M, Carter SL, Hofer MJ, et al. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T-cells in the central nervous system. J Immunol. 2007;179:2774-2786.
58. Krauthausen M, Ellis SL, Zimmermann J, et al. Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12. Am J Pathol. 2011;179:2346-2359.
59. Murphy PM. Chemokines. In: Paul WE, ed. Fundamental Immunology. 5th ed. Philadelphia, PA: Lippincott Williams & Williams; 2003;801-840.
60. Imaizumi T, Yoshida H, Satoh K. Regulation of CX3CL1/ fractalkine expression in endothelial cells. J Atheroscler Thromb. 2004;11:15-21.
61. Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004; 25:75-84.
62. Murphy PM. Chemokines. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Williams; 2008;804-833.
63. Goczalik I, Ulbricht E, Hollborn M, et al. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Invest Ophthalmol Vis Sci. 2008;49:4578-4589.